STOCK TITAN

Dräger receives AARC's 2024 Zenith Award for support of respiratory care

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Dräger has been awarded the 2024 Zenith Award by the American Association for Respiratory Care (AARC), marking the 13th time the company has received this recognition. The award, given to only eight out of over 300 companies, is based on criteria including equipment quality, service, and customer support. Dräger's commitment to the respiratory care profession is highlighted by its continuous investment in new technologies, such as the Evita V600, V800, and Babylog VN800 ventilators.

The company's services include a network of over 3000 technicians, remote service, and 24/7 hotline support. Dräger has also donated more than 320 ventilators to respiratory schools in the United States for training purposes. With revenues of around €3.4 billion in 2023, Dräger operates in over 190 countries with more than 16,000 employees worldwide.

Dräger ha ricevuto il Zenith Award 2024 dall'American Association for Respiratory Care (AARC), segnando la tredicesima volta che l'azienda ha ottenuto questo riconoscimento. Il premio, conferito a sole otto delle oltre 300 aziende, si basa su criteri quali qualità dell'attrezzatura, servizio e supporto clienti. L'impegno di Dräger nella professione della cura respiratoria è evidenziato dal suo continuo investimento in nuove tecnologie, come i ventilatori Evita V600, V800 e Babylog VN800.

I servizi dell'azienda includono una rete di oltre 3000 tecnici, assistenza remota e supporto telefonico attivo 24 ore su 24, 7 giorni su 7. Dräger ha anche donato più di 320 ventilatori alle scuole per la respirazione negli Stati Uniti per scopi formativi. Con un fatturato di circa 3,4 miliardi di euro nel 2023, Dräger opera in oltre 190 paesi con più di 16.000 dipendenti in tutto il mondo.

Dräger ha sido galardonada con el Zenith Award 2024 por la American Association for Respiratory Care (AARC), marcando la 13ª vez que la empresa recibe este reconocimiento. El premio, otorgado solo a ocho de más de 300 empresas, se basa en criterios como calidad del equipo, servicio y soporte al cliente. El compromiso de Dräger con la profesión del cuidado respiratorio se destaca por su inversión continua en nuevas tecnologías, como los ventiladores Evita V600, V800 y Babylog VN800.

Los servicios de la compañía incluyen una red de más de 3000 técnicos, servicio remoto y soporte telefónico 24/7. Dräger también ha donado más de 320 ventiladores a escuelas de respiración en los Estados Unidos para fines de capacitación. Con ingresos de aproximadamente 3.4 mil millones de euros en 2023, Dräger opera en más de 190 países con más de 16,000 empleados en todo el mundo.

드래거는 미국 호흡기 치료 협회(AARC)로부터 2024 제니스 어워드를 수상하였으며, 이는 회사가 이 인정을 받은 13번째 사례입니다. 이 상은 300개 이상의 회사 중 단 8개 회사에만 수여되며, 장비 품질, 서비스 및 고객 지원과 같은 기준에 기반합니다. 드래거의 호흡기 치료 직업에 대한 헌신은 신기술에 대한 지속적인 투자로 강조되며, 이는 Evita V600, V800 및 Babylog VN800 환기기를 포함합니다.

회사의 서비스에는 3000명 이상의 기술자 네트워크, 원격 서비스 및 24/7 핫라인 지원이 포함됩니다. 드래거는 또한 훈련 목적으로 미국의 호흡 치료 학교에 320대 이상의 환기기를 기부하였습니다. 2023년 약 34억 유로의 수익을 올린 드래거는 190개국 이상에서 16,000명 이상의 직원과 함께 활동하고 있습니다.

Dräger a reçu le Zenith Award 2024 de l'American Association for Respiratory Care (AARC), marquant la 13e fois que l'entreprise obtient cette reconnaissance. Le prix, décerné à seulement huit des plus de 300 entreprises, est basé sur des critères tels que la qualité des équipements, le service et le support client. L'engagement de Dräger envers la profession de soin respiratoire est souligné par un investissement continu dans de nouvelles technologies, comme les ventilateurs Evita V600, V800 et Babylog VN800.

Les services de l'entreprise comprennent un réseau de plus de 3000 techniciens, un service à distance et une assistance téléphonique 24/7. Dräger a également donné plus de 320 ventilateurs aux écoles de soins respiratoires aux États-Unis à des fins de formation. Avec un chiffre d'affaires d'environ 3,4 milliards d'euros en 2023, Dräger opère dans plus de 190 pays avec plus de 16 000 employés dans le monde entier.

Dräger wurde mit dem Zenith Award 2024 der American Association for Respiratory Care (AARC) ausgezeichnet, was die 13. Auszeichnung für das Unternehmen darstellt. Der Preis wird nur an acht von über 300 Unternehmen vergeben und basiert auf Kriterien wie Gerätequalität, Service und Kundenbetreuung. Das Engagement von Dräger für den Beruf der Atemwegspflege wird durch die kontinuierliche Investition in neue Technologien hervorgehoben, darunter die Beatmungsgeräte Evita V600, V800 und Babylog VN800.

Die Dienstleistungen des Unternehmens umfassen ein Netzwerk von über 3000 Technikern, Remote-Service und einen 24/7-Hotline-Support. Dräger hat auch mehr als 320 Beatmungsgeräte an Atemwegsschulen in den Vereinigten Staaten gespendet, um Ausbildungszwecke zu unterstützen. Mit einem Umsatz von rund 3,4 Milliarden Euro im Jahr 2023 ist Dräger in über 190 Ländern aktiv und beschäftigt mehr als 16.000 Mitarbeiter weltweit.

Positive
  • Received the prestigious 2024 Zenith Award from AARC for the 13th time
  • Continuous investment in new ventilator technologies (Evita V600, V800, Babylog VN800)
  • Extensive service network with over 3000 technicians and 24/7 support
  • Donated over 320 ventilators to respiratory schools for training purposes
  • Strong global presence with operations in over 190 countries
Negative
  • None.

Award criteria include quality of equipment, service and customer support

TELFORD, Pa., Sept. 24, 2024 /PRNewswire/ -- The American Association for Respiratory Care (AARC) selected Dräger for its 2024 Zenith Award. Presented to only eight out of more than 300 companies, this award enables the Association's members to recognize manufacturers and service organizations that have done outstanding work for them and their organizations. Selection criteria include quality of equipment and supplies, accessibility and helpfulness of sales personnel, responsiveness, service record, truth in advertising, and support of the respiratory care profession. This is the13th time AARC members have bestowed the award on Dräger.

In its announcement letter to Dräger, Daniel D. Garrett, CAE, Executive Director of the AARC, said: "Draeger, Inc. is a shining example of the qualities represented in the award criteria. Your dedication and commitment to the respiratory care profession have not gone unnoticed. We are deeply grateful for Draeger's continued support of the respiratory care profession. Your contributions have been invaluable."

"We are deeply honored to have been chosen by members of the AARC to receive this prestigious award," said President and CEO for Draeger, Inc., Lothar Thielen. "This award validates Dräger's longstanding commitment to the respiratory care profession – which extends from our CEO, Stefan Dräger, to our employees who support respiratory care professionals on a daily basis. We pledge to continue this commitment in the future."

Dräger continually invests in the development of new technologies and solutions, such as its new Evita V600, V800 and Babylog VN800 ventilators based on customer requirements for improving patient safety, patient outcomes, and hospital workflow. These devices can provide various modes of ventilation – such as high-flow O2 therapy, non-invasive ventilation, and invasive ventilation modes – using the same accessories. This eliminates the need to use multiple devices for critically ill patients who require different types of respiratory support, thereby streamlining workflow and reducing equipment costs.

Dräger's best-in-class services include a network of over 3000 technicians, remote service, 24/7 hotline support, and exceptional service follow up. The company also offers webinars and training classes for healthcare facilities that want to manage their own service. As of August 2024, Dräger donated more than 320 ventilators to respiratory schools in the United States to train the next generation of therapists and will donate another 10 ventilators by the end of the year.

Dräger. Technology for Life®

Dräger is an international leader in the fields of medical and safety technology. Our products protect, support, and save lives. Founded in 1889, Dräger generated revenues of around € 3.4 billion in 2023. The Dräger Group is currently present in over 190 countries and has more than 16,000 employees worldwide. Please visit www.draeger.com for more information.

Contact

Communications: Melanie Kamann, Tel. +49 451 882-3202, melanie.kamann@draeger.com

Press Contact North America: Laura Edwards, Tel. +1 215 565-5868, laura.edwards@draeger.com

Investor Relations: Thomas Fischler, Tel. +49 451 882-2685, thomas.fischler@draeger.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/drager-receives-aarcs-2024-zenith-award-for-support-of-respiratory-care-302257676.html

SOURCE Draeger

FAQ

What award did Dräger receive from AARC in 2024?

Dräger received the 2024 Zenith Award from the American Association for Respiratory Care (AARC) for its outstanding support of the respiratory care profession.

How many times has Dräger won the AARC Zenith Award?

Dräger has won the AARC Zenith Award 13 times, including the 2024 award.

What new ventilator technologies has Dräger developed?

Dräger has developed new ventilator technologies including the Evita V600, V800, and Babylog VN800 ventilators, which offer various modes of ventilation using the same accessories.

How many ventilators has Dräger donated to respiratory schools in the US?

As of August 2024, Dräger has donated more than 320 ventilators to respiratory schools in the United States for training purposes.

What was Dräger's revenue in 2023?

Dräger generated revenues of around €3.4 billion in 2023.

DRAEGERWERK AG ORD

OTC:DGWPF

DGWPF Rankings

DGWPF Latest News

DGWPF Stock Data

880.90M
11.48M
71.62%
8.39%
Medical Devices
Healthcare
Link
United States of America
Lübeck